Dyne Therapeutics To Present At Chardan’s Virtual 5th Annual Genetic Medicines Conference
Dyne Therapeutics, Inc. (NASDAQ:DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is